Nucleic Acid Controls
Cayman Chemical tetrnor-PGEM-d6 25ug
An internal standard for the quantification of tetranor-PGEM by GC- or LC-MS
Seracare Life Sciences Inc Seraseq ctDNA Mutation Mix v2 WT | 1 x 25 µL
To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations. This specific ctDNA Mutation Mix v2 product it the wild-type with an allele frequency of 0%.
US Biomax Inc Normal colon tissue array with colon cancer tissue as control, including TNM, clinical stage and pathology grade, 24 cases/ 72 cores, unstained slide
Normal colon tissue microarray, containing 19 cases of normal colon tissue, 2 cases of cancer adjacent normal colon tissue, plus 3 cases of colon adenocarcinoma, triplicate cores per case
ATCC Quantitative Genomic RNA from Influenza A Virus (H3N2) - strain A/Baltimore/JH-0440/2022, 100 μL (VR-3401D)
This quantitative genomic RNA preparation is intended for assay development, verification, and qPCR standard curve generation to determine viral load.
- Material type: genomic RNA.
- Organism/strain: Influenza A virus (H3N2) - A/Baltimore/JH-0440/2022.
- Packaging/volume: 100 μL.
- Storage conditions: -70°C or colder.
- Product format: frozen.
- Biosafety level: BSL 1.
- Verification method: whole-genome sequencing.
- Applications: assay development, verification and validation, infectious and respiratory disease research.
